|
|
|
|
|
| |Product Pipeline |Product Portfolio   |
| Cardiovascular Diseases | Central Nervous System Disorders | Infectious Diseases | | Arthritis/Inflammation | Metabolic Diseases | Allergic Diseases | | Cancer | Genitourinary/Sexual Health | Surgery/Interventional | | Consumer Health/OTC | Animal Health | | |
| ||
| MAJOR PFIZER PRODUCTS AND SELECTED CANDIDATES IN DEVELOPMENT | ||
| Allergic Diseases | ||
| Current Products | ||
| Reactine [I]3 Zyrtec [U.S.]3 (tablets and syrup) |
||
| Extensions / Additional Indications (last 12 months) | Under Regulatory Review | In Advanced-Stage Development |
|
Zyrtec [U.S.] (for pediatric use, ages 2-5) |
Zyrtec-D (cetirizine HCl and pseudoephedrine HCl) | |
| Key: [U.S.]—U.S. only [I]—International only (in at least one country) No Key—Both U.S. and at least one other country 3Copromoted by UCB Pharmaceuticals and Pfizer; trademark of UCB | ||
|
|
|
| ||||
 |
 |
 |
 | |
| ||||
 |
||||
 |
||||
| Advisory Information for Investors | ||||
| Copyright © 1997, 1998 Pfizer Inc All rights reserved. | ||||
| ||||